Skip to main content
SpringerLink
Log in

Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Taher AT, Weatherall DJ, Cappellini MD (2018) Thalassaemia. Lancet 391:155–167

    Article  Google Scholar 

  2. Taher AT, Musallam KM, Saliba AN, Graziadei G, Cappellini MD (2015) Hemoglobin level and morbidity in non-transfusion-dependent thalassemia. Blood Cells Mol Dis 55:108–109

    Article  CAS  Google Scholar 

  3. Musallam KM, Cappellini MD, Daar S, Karimi M, El-Beshlawy A, Graziadei G, Magestro M, Wulff J, Pietri G, Taher AT (2014) Serum ferritin level and morbidity risk in transfusion-independent patients with beta-thalassemia intermedia: the ORIENT study. Haematologica 99:e218–e221

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Network of Hematology, London, UK

    Khaled M. Musallam

  2. Department of Clinical Sciences and Community, University of Milan, Milan, Italy

    Maria Domenica Cappellini

  3. Department of Hematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

    Shahina Daar

  4. Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Beirut, 11072020, Lebanon

    Ali T. Taher

Authors
  1. Khaled M. Musallam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Domenica Cappellini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shahina Daar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ali T. Taher
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study design: K.M.M., A.T.T.; data collection: A.T.T., M.D.C., S.D.; data analysis: K.M.M.; manuscript drafting: K.M.M.; manuscript review for important intellectual content: K.M.M., M.D.C., S.D., A.T.T. All authors gave final approval for submission.

Corresponding author

Correspondence to Ali T. Taher.

Ethics declarations

Conflict of interest

K.M.M. has been or is a consultant for Novartis, Celgene Corp (Bristol Myers Squibb), Agios Pharmaceuticals, CRISPR Therapeutics, and Vifor Pharma. M.D.C. has been or is a consultant for Novartis, Celgene Corp (Bristol Myers Squibb), Vifor Pharma and Ionis Pharmaceuticals, and received research funding from Novartis, Celgene Corp (Bristol Myers Squibb), La Jolla Pharmaceutical Company, Roche, Protagonist Therapeutics and CRISPR Therapeutics. S.D. has nothing to disclose. A.T.T. has been or is a consultant for Novartis, Celgene Corp (Bristol Myers Squibb), Vifor Pharma, Silence Therapeutics and Ionis Pharmaceuticals, and received research funding from Novartis, Celgene Corp (Bristol Myers Squibb), La Jolla Pharmaceutical Company, Roche, Protagonist Therapeutics and Agios Pharmaceuticals.

Ethical approval

Data were collected as part of now completed clinical studies, which were approved by the Institutional Review Board at all institutions. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

All patients had signed an informed consent form for participating in the original studies in accordance with the Declaration of Helsinki.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Musallam, K.M., Cappellini, M.D., Daar, S. et al. Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study. Ann Hematol 101, 203–204 (2022). https://doi.org/10.1007/s00277-020-04370-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04370-2

Search

Navigation